{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2
  ],
  "modelUsed": "gemini-3-flash-preview",
  "metadata": {
    "studyName": "A Phase 3 Open-Label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous",
    "titles": [
      {
        "id": "title_1",
        "text": "A Phase 3 Open-Label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (rFVIIIFc-VWF-XTEN; BIVV001) in Previously Treated Patients ≥12 Years of Age With Severe Hemophilia A",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "XTEND-1",
        "type": {
          "code": "Study Acronym",
          "codeSystem": "USDM",
          "decode": "Study Acronym"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "NCT04161495",
        "scopeId": "org_3",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "NCT",
          "codeSystem": "USDM",
          "decode": "ClinicalTrials.gov Identifier"
        }
      },
      {
        "id": "sid_2",
        "text": "EFC16293",
        "scopeId": "org_1",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "SponsorProtocolNumber",
          "codeSystem": "USDM",
          "decode": "Sponsor Protocol Number"
        }
      },
      {
        "id": "sid_3",
        "text": "2019-002023-15",
        "scopeId": "org_eudract",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "EudraCT",
          "codeSystem": "USDM",
          "decode": "EudraCT Number"
        }
      },
      {
        "id": "sid_4",
        "text": "17464",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "IND",
          "codeSystem": "USDM",
          "decode": "FDA IND Number"
        }
      },
      {
        "id": "sid_5",
        "text": "U1111-1223-4867",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "WHO_UTN",
          "codeSystem": "USDM",
          "decode": "WHO Universal Trial Number"
        }
      },
      {
        "id": "sid_6",
        "text": "VV-CLIN-0548164 7.0",
        "scopeId": "org_1",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "SponsorProtocolNumber",
          "codeSystem": "USDM",
          "decode": "Sponsor Protocol Number"
        }
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Bioverativ Therapeutics Inc. (a Sanofi Company)",
        "type": {
          "id": "9cde0d9f-c89d-4e33-974a-507260731780",
          "code": "C54086",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "identifier": "Bioverativ Therapeutics Inc. (a Sanofi Company)",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "Sanofi",
        "type": {
          "id": "3f992a9a-e760-49ec-8be7-07e1f92e2503",
          "code": "C54086",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "identifier": "Sanofi",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "ClinicalTrials.gov",
        "type": {
          "id": "6ac45db7-4264-4e56-86c6-ebdd7aefd6ab",
          "code": "C19326",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Healthcare Facility",
          "instanceType": "Code"
        },
        "identifier": "ClinicalTrials.gov",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      }
    ],
    "roles": [
      {
        "id": "role_1",
        "name": "Sponsor",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_1"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_2",
        "name": "Parent Company",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_2"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_3",
        "name": "Registry",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_3"
        ],
        "instanceType": "StudyRole"
      }
    ],
    "indications": [
      {
        "id": "ind_1",
        "name": "Severe Hemophilia A",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Previously treated patients ≥12 years of age with severe Hemophilia A"
      }
    ],
    "studyPhase": {
      "code": "Phase3",
      "codeSystem": "USDM",
      "decode": "Phase3"
    },
    "studyType": "Interventional"
  },
  "rawResponse": {
    "titles": [
      {
        "id": "title_1",
        "text": "A Phase 3 Open-Label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (rFVIIIFc-VWF-XTEN; BIVV001) in Previously Treated Patients ≥12 Years of Age With Severe Hemophilia A",
        "type": {
          "code": "OfficialStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "XTEND-1",
        "type": {
          "code": "StudyAcronym",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Study Acronym"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "NCT04161495",
        "identifierType": "NCT",
        "issuingOrganization": "ClinicalTrials.gov",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "EFC16293",
        "identifierType": "SponsorProtocolNumber",
        "issuingOrganization": "Bioverativ Therapeutics Inc.",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_3",
        "text": "2019-002023-15",
        "identifierType": "EudraCT",
        "issuingOrganization": "EudraCT",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_4",
        "text": "17464",
        "identifierType": "IND",
        "issuingOrganization": "FDA",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_5",
        "text": "U1111-1223-4867",
        "identifierType": "WHO_UTN",
        "issuingOrganization": "WHO",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_6",
        "text": "VV-CLIN-0548164 7.0",
        "identifierType": "InternalStudyID",
        "issuingOrganization": "Sanofi",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Bioverativ Therapeutics Inc. (a Sanofi Company)",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "role": "Sponsor",
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "Sanofi",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "role": "Parent Company",
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "ClinicalTrials.gov",
        "type": {
          "code": "Registry",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Clinical Study Registry"
        },
        "role": "Registry",
        "instanceType": "Organization"
      }
    ],
    "studyPhase": {
      "code": "Phase3",
      "codeSystem": "http://www.cdisc.org/USDM/studyPhase",
      "decode": "Phase 3"
    },
    "studyType": "Interventional",
    "indication": {
      "id": "ind_1",
      "name": "Severe Hemophilia A",
      "description": "Previously treated patients ≥12 years of age with severe Hemophilia A",
      "instanceType": "Indication"
    }
  }
}